Development and International Evaluation of an Artificial Intelligence–based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non–muscle-invasive Bladder Cancer

Journal:
European Urology
Published:
DOI:
10.1016/j.eururo.2025.09.4145
Affiliations:
22
Authors:
31
Go to article
Institutions Authors Share
University of Toronto (U of T), Canada
7.848485
 0.25
University Health Network (UHN), U of T, Canada
3.378788
 0.11
The University of Texas MD Anderson Cancer Center, United States of America (USA)
2.045455
 0.07
Institute Jules Bordet, ULB, Belgium
2.045455
 0.07
Mount Sinai Hospital (MSH), U of T, Canada
1.378788
 0.04
Trillium Health Partners, Canada
1.378788
 0.04
University of Alberta (U of A), Canada
1.045455
 0.03
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Netherlands
1.045455
 0.03
Dalhousie University, Canada
1.045455
 0.03
CHU de Québec, UL, Canada
1.045455
 0.03
European Organisation for Research and Treatment of Cancer (EORTC), Belgium
1.045455
 0.03
University of Calgary (U of C), Canada
1.045455
 0.03
University of Turin (UNITO), Italy
1.045455
 0.03
Hospital of the University of Montreal (CHUM), Canada
1.045455
 0.03
The Ottawa Hospital (TOH), Canada
1.045455
 0.03
McGill University Health Centre (MUHC), Canada
1.045455
 0.03
The University of British Columbia (UBC), Canada
1.045455
 0.03
University of Sherbrooke (USherbrooke), Canada
1.045455
 0.03
Vector Institute, Canada
0.378788
 0.01
Interested in Oncology and Carcinogenesis?